Clinical trial
Prospective Double-blind, Placebo Controlled Study to Assess the Efficacy of Intralesional Corticoid on the Treatment of Frontal Fibrosing Alopecia
NCT02467101 is registered in ClinicalTrials.gov with Rubina Alves as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Double-blind, Placebo Controlled Study to Assess the Efficacy of Intralesional Corticoid on the Treatment of Frontal Fibrosing Alopecia
- Lead sponsor
- Rubina Alves
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 31, 2015
- Completion date
- December 31, 2015
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
frontal fibrosing alopecia